Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Ridler

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Internal Medicine|February 1, 1990
Heparin inhibits spontaneous thrombolysis and the thrombolytic effect of both streptokinase and tissue-type plasminogen activator. An in vitro study of the dislodgement of platelet-rich thrombi formed from native bloodP Görög, C D Ridler, I B Kovacs
Thrombosis Research|August 15, 1995
Evidence against hypercoagulability in coronary artery diseaseP Görög, C D Ridler, G M Rees, et al.
Angiology|April 1, 1992
Hemostatic abnormalities in Sneddon's syndromeS C Mayou, I B Kovacs, C D Ridler, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|October 3, 1998
Thrombogenic and atherogenic lipid modifications in plasma and patients with coronary artery disease and after coronary artery bypass surgeryI B Kovacs, M Jahangiri, C D Ridler, et al.
The Annals of Thoracic Surgery|April 24, 1999
Coronary artery surgery is associated with different forms of atherogenic lipoprotein modificationsM Jahangiri, I B Kovacs, C D Ridler, et al.
American Journal of Hematology|August 1, 1992
Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemiaS I Berney, C D Ridler, A D Stephens, et al.
Thrombosis Research|August 15, 1993
Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitroJ Yamamoto, I Ishii, Y Okada, et al.
International Journal of Cardiology|April 1, 1992
Significance of plasma fibrinogen in coronary arterial disease: marker or causative risk factor for arterial thrombosis?I B Kovacs, C P Ratnatunga, C D Ridler, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Internal Medicine|February 1, 1990
Heparin inhibits spontaneous thrombolysis and the thrombolytic effect of both streptokinase and tissue-type plasminogen activator. An in vitro study of the dislodgement of platelet-rich thrombi formed from native bloodP Görög, C D Ridler, I B Kovacs
Thrombosis Research|August 15, 1995
Evidence against hypercoagulability in coronary artery diseaseP Görög, C D Ridler, G M Rees, et al.
Angiology|April 1, 1992
Hemostatic abnormalities in Sneddon's syndromeS C Mayou, I B Kovacs, C D Ridler, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|October 3, 1998
Thrombogenic and atherogenic lipid modifications in plasma and patients with coronary artery disease and after coronary artery bypass surgeryI B Kovacs, M Jahangiri, C D Ridler, et al.
The Annals of Thoracic Surgery|April 24, 1999
Coronary artery surgery is associated with different forms of atherogenic lipoprotein modificationsM Jahangiri, I B Kovacs, C D Ridler, et al.
American Journal of Hematology|August 1, 1992
Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemiaS I Berney, C D Ridler, A D Stephens, et al.
Thrombosis Research|August 15, 1993
Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitroJ Yamamoto, I Ishii, Y Okada, et al.
International Journal of Cardiology|April 1, 1992
Significance of plasma fibrinogen in coronary arterial disease: marker or causative risk factor for arterial thrombosis?I B Kovacs, C P Ratnatunga, C D Ridler, et al.
Pageof 1